ADCplex K5
/ HighField Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2026
ADCplex K5: A Dual-Antibody, Triple-Payload Liposomal Antibody–Drug Complex Designed to Overcome Tumor Heterogeneity Through Multi-Mechanistic Cytotoxic Targeting With Reduced Systemic Toxicity
(ESMO 2026)
- No abstract available
ADC • Heterogeneity • Oncology
1 to 1
Of
1
Go to page
1